Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Invested Capital (2022 - 2026)

Updated

Pelthos Therapeutics' Invested Capital came in at $25.09 million for Q2 2026, compared with -$6.36 million a year earlier and down 45.0% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Invested Capital (2022 - 2026) Analysis & Trends

For FY2025, Pelthos Therapeutics' Invested Capital was $38.88 million.

  • Going back by year, Invested Capital was -$396,000 in FY2024, -$5.69 million in FY2023 and -$3.6 million in FY2022.
  • The five-year range for quarterly Invested Capital is -$6.36 million (Q2 2025) to $45.62 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Pelthos Therapeutics 76.83 Mn -11.57 Mn 11.99 Mn 25.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.09 Mn
Mar 31, 2026 45.62 Mn
Dec 31, 2025 38.88 Mn
Jun 30, 2025 -6.36 Mn
Mar 31, 2025 -4.06 Mn
Dec 31, 2024 -396,000.00
Sep 30, 2024 -1.30 Mn
Jun 30, 2024 -52,132.00
Dec 31, 2023 -5.69 Mn
Dec 31, 2022 -3.60 Mn
API Access

Pelthos Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=PTHS&period=max&api_key=YOUR_API_KEY